Charles Leduc
- Biochemistry top 2%
-
- Natural Antidiabetic Agents Studies 5
- Geriatrics and Gerontology top 10%
- Pharmacology top 10%
-
- Lung Cancer Treatments and Mutations 6
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 5
- Lung Cancer Diagnosis and Treatment 4
- Medical Imaging and Pathology Studies 3
-
- Cardiac tumors and thrombi 3
-
- Lymphoma Diagnosis and Treatment 3
-
- Vascular Tumors and Angiosarcomas 2
- Co-authors
- Pierre S. HaddadAlain CuerrierJohn T. ArnasonLouis C. MartineauBouchra MeddahAli Benhaddou-AndaloussiSteffany A. L. BennettCory S. Harris
- Journals
- Journal of Thoracic Oncology (3 papers)International Journal for Population Data Science (3 papers)Cardiovascular Pathology (2 papers)
- Partner nations
- CanadaUnited StatesAustralia
In The Last Decade
Charles Leduc
39 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 110
- Biochemistry 209
- Endocrinology, Diabetes and Metabolism 331
- Complementary and alternative medicine 82
- Geriatrics and Gerontology 31
- Pharmacology 58
Countries citing papers authored by Charles Leduc
This map shows the geographic impact of Charles Leduc's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles Leduc with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles Leduc more than expected).
Fields of papers citing papers by Charles Leduc
This network shows the impact of papers produced by Charles Leduc. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles Leduc. The network helps show where Charles Leduc may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Charles Leduc, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 1 | |
| 3 | 2023 | 16 | |
| 4 | 2021 | 20 | |
| 5 | 2021 | 34 | |
| 6 | 2020 | 20 | |
| 7 | 2020 | 4 | |
| 8 | 2020 | 2 | |
| 9 | 2019 | 20 | |
| 10 | 2018 | 9 | |
| 11 | 2018 | 13 | |
| 12 | 2016 | 23 | |
| 13 | 2015 | 22 | |
| 14 | 2014 | 3 | |
| 15 | 2012 | 45 | |
| 16 | 2008 | 61 | |
| 17 | 2007 | 179 | |
| 18 | 2005 | 120 | |
| 19 | 2004 | 15 | |
| 20 | 1996 | 64 |
About Charles Leduc
Charles Leduc is a scholar working on Geriatrics and Gerontology, Pathology and Forensic Medicine and Pulmonary and Respiratory Medicine, having authored 42 papers that have together received 1.2k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (6 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (5 papers), Natural Antidiabetic Agents Studies (5 papers), Lung Cancer Diagnosis and Treatment (4 papers), Medical Imaging and Pathology Studies (3 papers), Cardiac tumors and thrombi (3 papers), Lymphoma Diagnosis and Treatment (3 papers) and Vascular Tumors and Angiosarcomas (2 papers). The work is most often cited by research in Biochemistry (209 citations), Endocrinology, Diabetes and Metabolism (331 citations) and Complementary and alternative medicine (82 citations). Charles Leduc has collaborated with scholars based in Canada, United States and Australia. Frequent co-authors include Pierre S. Haddad, Alain Cuerrier, John T. Arnason, Louis C. Martineau, Bouchra Meddah, Ali Benhaddou-Andaloussi, Steffany A. L. Bennett, Cory S. Harris, Tri Vuong and Joseph J. Maleszewski. Their work appears in journals such as Journal of Thoracic Oncology, International Journal for Population Data Science, Cardiovascular Pathology, Legal Medicine and Neoplasia.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.